According to an international research team, a new type of gene variant could influence fasting blood glucose levels via melatonin metabolism . The gene is closely associated with increased blood glucose levels and a higher risk of type 2 diabetes .
The new finding could potentially enhance diabetes treatment possibilities, taking treatment horizons beyond currently used symptomatic therapy approaches for diabetes treatment .
To reach their conclusions, the MAGIC Consortium (Meta Analyses of Glucose and Insulin -related traits Consortium) analysed data from 13 difference case-control studies, with over 18,000 diabetic participants.
The results of the study were published in the January issue of journal Nature Genetics .

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…